Freeze-Dried Rabies Vaccine

As a leading vaccine manufacturer, AIM Honor's freeze-dried rabies vaccine utilizes advanced freeze-drying technology and a highly effective local aG strain. It is available only in intramuscular injection form, boasts a 100% seroconversion rate within 14 days, and its potency far exceeds the WHO 2.5 IU/dose standard.

What is a Freeze-dried Rabies Vaccine?

Freeze-dried Rabies Vaccine is a high-performance preventive vaccine designed for rabies prevention, using the rabies virus fixed strain aG with strong immunogenicity as the core raw material. Through strict processes of Vero cell culture, virus harvest, concentration, inactivation, and multi-step purification, the vaccine ensures high antigen purity and low impurity residue. The freeze-drying process adopted effectively retains the biological activity of the antigen while reducing the product volume, making it convenient for storage, transportation, and use in various environments.

After vaccination, the vaccine can quickly stimulate the body's immune system to produce specific neutralizing antibodies against rabies virus, forming a strong protective barrier within a short time. It is applicable to post-exposure emergency prevention for individuals bitten, scratched, or licked by rabid animals (such as dogs, cats, bats, etc.), as well as pre-exposure immunization for high-risk groups. The product has been tested in a large number of clinical trials and post-marketing applications, proving its excellent safety and effectiveness, with mild and transient adverse reactions that can subside on their own without special treatment.

Core Advantages

Freeze-drying activity-locking technology: Adopts advanced freeze-drying process to maximize the retention of antigen biological activity; takes effect quickly after reconstitution with stable immune effect.

Ultra-high safety: No preservatives or antibiotic residues; strictly controls impurity content; the incidence of adverse reactions is lower than the industry average, suitable for special populations such as children and the elderly.

Convenient storage: Freeze-dried dosage form is small in size, light in weight, and not easy to break; can be stored under conventional refrigeration at 2-8℃, facilitating long-distance transportation and storage in primary medical institutions.

Application Scenarios

Primary medical care: Freeze-dried rabies vaccine can be used for daily post-exposure rabies vaccination in community hospitals, township health centers, etc.

Emergency prevention and control: Emergency vaccination for sudden exposure incidents in rabies-endemic areas to quickly establish immune protection.

Cross-border procurement: AIM Honor is a professional supplier, supports global procurement and export to meet the rabies prevention and control needs of different countries and regions.

How Do We Produce the Vaccine?

The production of Freeze-dried Rabies Vaccine is carried out in a GMP-certified professional workshop, with the entire process strictly in line with international biopharmaceutical quality standards:

High-purity antigen preparation: Uses large-scale Vero cell culture technology, combined with 100KD imported membrane ultrafiltration and chromatography purification processes, to effectively remove foreign proteins, DNA, and other impurities, ensuring antigen purity.

Precision freeze-drying control: The preparation process is fully controlled in a B+A grade clean environment, with a 40m² large-scale freeze-drying system to accurately control the freeze-drying curve, reducing product moisture content and ensuring long-term stability.

Strict quality inspection: Each batch of products undergoes multiple quality tests, including potency, sterility, endotoxin, and impurity residue, with a 100% batch release qualification rate, ensuring that every vial of vaccine meets high-quality standards.

Examples of production details images: clean room, freeze-drying equipment

Company Information

Manufacturer: AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. (Subsidiary of AIM Vaccine)

Parent Company: AIM Vaccine Co., Ltd. (Stock Code: 06660.HK)

Address of Parent Company: 25th Floor, Block A, Jindi Center, No. 91 Jianguo Road, Chaoyang District, Beijing, China

Postal Code: 100022

Phone: +86-10-85950063

Address of Manufacturer: 21 Chuangye Avenue, West Bonded Area, Beilun District, Ningbo, Zhejiang Province, China

Postal Code: 315800

Tel.: +86-574-86822165

Fax: +86-574-86869285

Website: www.aimbio.com; www.chinarongan.com; www.aimvaccine.com

Approval Document No.: National Drug Approval Number S20073014